Boule Diagnostics AB (publ) (STO:BOUL)
3.650
+0.140 (3.99%)
Jul 24, 2026, 5:29 PM CET
Boule Diagnostics AB Market Cap
Boule Diagnostics AB has a market cap or net worth of 141.74 million as of July 24, 2026. Its market cap has decreased by -44.70% in one year.
Market Cap
141.74M
Enterprise Value
349.44M
Revenue
461.29M
Ranking
n/a
PE Ratio
n/a
Stock Price
3.65
ChartMarket Cap Chart
Since June 23, 2011, Boule Diagnostics AB's market cap has decreased from 162.45M to 141.74M, a decrease of -12.75%. That is a compound annual growth rate of -0.90%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 24, 2026 | 141.74M | -25.66% |
| Dec 30, 2025 | 190.67M | -45.32% |
| Dec 30, 2024 | 348.72M | -19.96% |
| Dec 29, 2023 | 435.71M | -25.70% |
| Dec 30, 2022 | 586.38M | -38.11% |
| Dec 30, 2021 | 947.53M | -17.98% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Q-linea AB | 312.65M |
| Acarix AB | 292.72M |
| BrainCool AB | 288.26M |
| Episurf Medical AB | 250.00M |
| Integrum AB | 220.81M |
| Promimic AB | 188.92M |
| Scandinavian Real Heart AB (Publ) | 158.91M |
| Nosa Plugs AB | 129.83M |